Table 4.
Peak VO2 during the sprints, pain felt during the 60 s occlusions and hemoglobin concentration before the sprints (mean ± SD).
| A | B | C | Treatment | Treat × Sex | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sprints VO2peak (mL min−1) |
All | 2668 | ± | 597 | 2650 | ± | 581 | 2624 | ± | 566 | 0.290 | 0.110 |
| M | 3160 | ± | 391 | 3099 | ± | 425 | 3046 | ± | 453 | |||
| W | 2177 | ± | 265 | 2178 | ± | 252 | 2202 | ± | 279 | |||
| Pain 15 s L | All | 7.9 | ± | 1.5 | 8.1 | ± | 1.7 | 7.6 | ± | 2.0 | 0.11 | 0.29 |
| M | 7.6 | ± | 1.6 | 7.9 | ± | 1.8 | 7.0 | ± | 2.4 | |||
| W | 8.3 | ± | 1.3 | 8.3 | ± | 1.6 | 8.2 | ± | 1.5 | |||
| Pain 35 s L | All | 8.6 | ± | 1.2 | 8.6 | ± | 1.9 | 8.4 | ± | 1.7 | 0.12 | 0.35 |
| M | 8.5 | ± | 1.3 | 8.6 | ± | 1.4 | 8.1 | ± | 2.1 | |||
| W | 8.7 | ± | 1.2 | 8.6 | ± | 2.4 | 8.8 | ± | 1.2 | |||
| Pain 55 s L | All | 9.1 | ± | 1.1 | 9.3 | ± | 1.1 | 9.2 | ± | 1.0 | 0.20 | 0.27 |
| M | 9.0 | ± | 1.2 | 9.1 | ± | 1.3 | 9.1 | ± | 1.1 | |||
| W | 9.3 | ± | 0.9 | 9.6 | ± | 0.8 | 9.3 | ± | 0.9 | |||
| Mean Pain L | All | 8.5 | ± | 1.2 | 8.7 | ± | 1.3 | 8.4 | ± | 1.5 | 0.12 | 0.61 |
| M | 8.4 | ± | 1.3 | 8.5 | ± | 1.4 | 8.1 | ± | 1.8 | |||
| W | 8.7 | ± | 1.1 | 9.0 | ± | 1.1 | 8.7 | ± | 1.1 | |||
| Hemoglobin (g dL−1) | All | 14.3 | ± | 1.3 | 14.4 | ± | 1.3 | 14.4 | ± | 1.2 | 0.70 | 0.09 |
| M | 15.4 | ± | 0.7 | 15.5 | ± | 0.7 | 15.3 | ± | 0.6 | |||
| W | 13.2 | ± | 0.7 | 13.3 | ± | 0.8 | 13.4 | ± | 0.7 | |||
M: men; W: women; Pain 15 s: pain reported at the 15th s of the occlusion; Pain 35 s: pain reported at the 35th s of the occlusion; Pain 55 s: pain reported at the 55th s of the occlusion; L analysis done with logarithmically transformed data. N = 39–40 for all variables.